Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
Clinical trial NCT05541250 · RECRUITING
Trial details
- NCT number
- NCT05541250
- Sponsor
- W. Dalton Dietrich
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-04
- Primary completion
- 2026-09-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.